Lipoxin analogs and lipoxin formation in vivo

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 239-243

  Romano, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; LIPOXIN; LIPOXIN A; LIPOXIN B; STEROID;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; BLOOD VESSEL INJURY; BOLUS INJECTION; BRONCHOSPASM; CAPILLARY LEAK SYNDROME; COLITIS; DOWN REGULATION; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; EAR; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID SYNTHESIS; GASTRITIS; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEMATOCHEZIA; HUMAN; IMMUNOLOGICAL PARAMETERS; IN VIVO STUDY; INTESTINE EPITHELIUM; KIDNEY FUNCTION; LITERATURE; LIVER FUNCTION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REPERFUSION INJURY; REVIEW; SKIN; SKIN ALLERGY; SKIN INFLAMMATION; STOMACH INJURY; WEIGHT REDUCTION;

EID: 24344453922     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.011     Document Type: Article

References (37)

1. 4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products Biochemistry 32 1993 6313 6319
2. 4 12- hydroxydehydrogenase in inflammation J. Biol. Chem. 275 2000 25372 25380
3. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction J. Exp. Med. 183 1996 137 146
4. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
5. 4 stable analogues J. Clin. Invest. 101 1998 819 826
6. 4 stable analog displays a unique topical anti-inflammatory profile J. Immunol. 169 2002 7063 7070
7. 4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo J. Med. Chem. 47 2004 2157 2165
8. M.O. Leonard, K. Hannan, and M.J. Burne 15-Epi-16-(para-fluorophenoxy)- lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure J. Am. Soc. Nephrol. 13 2002 1657 1662
9. N.E. Kieran, P.P. Doran, and S.B. Connolly Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog Kidney Int. 64 2003 480 492
10. K.F. Badr, C.N. Serhan, K.C. Nicolaou, and B. Samuelsson The action of lipoxin-A on glomerular microcirculatory dynamics in the rat Biochem. Biophys. Res. Commun. 145 1987 408 414
11. 4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors J. Biol. Chem. 275 2000 27566 27575
12. M. Pouliot, C.B. Clish, N.A. Petasis, T.E. Van Dyke, and C.N. Serhan Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease Biochemistry 39 2000 4761 4768
13. 4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases J. Periodontal. Res. 34 1999 370 373
14. 4 increases gastric resistance to aspirin-induced damage Gastroenterology 123 2002 1598 1606
15. S. Fiorucci, L. Santucci, and J.L. Wallace Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Proc. Natl. Acad. Sci. USA 100 2003 10937 10941
16. A.T. Gewirtz, A.S. Neish, and J.L. Madara Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins Adv. Exp. Med. Biol. 507 2002 229 236
17. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J. Immunol. 168 2002 5260 5267
18. 4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc. Natl. Acad. Sci. USA 101 2004 15736 15741
19. 4 on airway responses in asthmatic subjects Am. Rev. Respir. Dis. 145 1992 1281 1284
20. B.D. Levy, G.T. De Sanctis, and P.R. Devchand Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4) Nat. Med. 8 2002 1018 1023
21. 4 block allergen-induced eosinophil trafficking J. Immunol. 164 2000 2267 2271
22. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia J. Immunol. 164 2000 1029 1036
23. C.L. Karp, L.M. Flick, and K.W. Park Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway Nat. Immunol. 5 2004 388 392
24. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion J. Clin. Invest. 104 1999 309 316
25. 4 FASEB J. 16 2002 1937 1939
26. S.J. Campbell, P.M. Hughes, and J.P. Iredale CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury FASEB J. 17 2003 1168 1170
27. P.R. Devchand, B.A. Schmidt, and V.C. Primo A synthetic eicosanoid LX-mimetic unravels host-donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils FASEB J. 19 2005 203 210
28. T.H. Lee, A.E. Crea, and V. Gant Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases Am. Rev. Respir. Dis. 141 1990 1453 1458
29. D.A. Brezinski, R.W. Nesto, and C.N. Serhan Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy Circulation 86 1992 56 63
30. 4-ELISA Lipids 28 1993 1047 1053
31. 4 ELISA J. Pharmacol. Exp. Ther. 287 1998 779 790
32. M. Romano, G. Luciotti, and S. Gangemi Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins Lab. Invest. 82 2002 1253 1254
33. 4 and related compounds J. Appl. Physiol. 94 2003 2237 2240
34. N. Li, N.H. Wallen, and P. Hjemdahl Evidence for prothrombotic effects of exercise and limited protection by aspirin Circulation 100 1999 1374 1379
35. N. Chiang, E.A. Bermudez, P.M. Ridker, S. Hurwitz, and C.N. Serhan Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial Proc. Natl. Acad. Sci. USA 101 2004 15178 15183
36. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 7 2001 612 619
37. I. Vachier, C. Bonnans, and C. Chavis Severe asthma is associated with a loss of LXA4, an endogenous anti-inflammatory compound J. Allergy Clin. Immunol. 115 2005 55 60